Elicio Therapeutics Patents – Key Insights and Stats

Elicio Therapeutics has a total of 31 patents globally, out of which 0 have been granted. Of these 131 patents, 93% patents are active. Hong Kong is where Elicio Therapeutics has filed the maximum number of patents, followed by United States Of America and Malaysia. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Elicio Therapeutics.

Elicio Therapeutics was founded in 2011. Elicio Therapeutics operates as a clinical-stage biotechnology company. The Company develops pipeline of novel immunotherapies for the treatment of cancer and other diseases. Elicio Therapeutics serves patients worldwide. As of May 2022 Elicio Therapeutics has a market cap of $180.42 Million.

Do read about some of the most popular patents of Elicio Therapeutics which have been covered by us in this article and also you can find Elicio Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Elicio Therapeutics patent portfolio.

How many patents does the CEO of Elicio Therapeutics have?

The CEO, Robert Connelly has 0 patents.

How many patents does Elicio Therapeutics have?

Elicio Therapeutics has a total of 31 patents globally. These patents belong to 4 unique patent families. Out of 31 patents, 29 patents are active.

How Many Patents did Elicio Therapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantElicio Therapeutics Applications FiledElicio Therapeutics Patents Granted
20171
201922
20203
20215

How many Elicio Therapeutics patents are Alive/Dead?

Worldwide Patents

How Many Patents did Elicio Therapeutics File in Different Countries?

Countries in which Elicio Therapeutics Filed Patents

CountryPatents
Hong Kong (S.A.R.)4
United States Of America3
Malaysia2
Japan2
China2
Europe2
Mexico2
Canada2
Singapore2
Brazil2
Australia2
Israel2
India1

What Percentage of Elicio Therapeutics US Patent Applications were Granted?

Elicio Therapeutics (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.00%.

Below are the key stats of Elicio Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Elicio Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Clark & Elbing30%
Nelson Mullins Riley & Scarborough10%

EXCLUSIVE INSIGHTS COMING SOON!

What are Elicio Therapeutic’s key innovation segments?

What Technologies are Covered by Elicio Therapeutics

The chart below distributes patents filed by Elicio Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Elicio Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Elicio Therapeutic’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Elicio Therapeutics?

Updated on June 6, 2022

Was this article helpful?

Leave a Comment